You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 23, 2024

CLINICAL TRIALS PROFILE FOR BETAINE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for BETAINE

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00152815 ↗	Non-alcoholic Fatty Liver Disease (NAFLD) in HIV: The Role of Nutritional Interventions	Terminated	Ontario HIV Treatment Network	Phase 2	2003-10-01	The purpose of this study is to evaluate the effect of a one-year nutritional intervention with either betaine or vitamin E supplementation, or a weight reducing diet and exercise program on liver steatosis and steatohepatitis.
NCT00152815 ↗	Non-alcoholic Fatty Liver Disease (NAFLD) in HIV: The Role of Nutritional Interventions	Terminated	Johane Allard	Phase 2	2003-10-01	The purpose of this study is to evaluate the effect of a one-year nutritional intervention with either betaine or vitamin E supplementation, or a weight reducing diet and exercise program on liver steatosis and steatohepatitis.
NCT00226356 ↗	Natural Supplements for Unipolar Depression	Completed	National Alliance for Research on Schizophrenia and Depression	Phase 4	2004-12-01	This study is being conducted to determine the clinical response rate for the regimen of L-methionine, betaine and folate for unipolar depression.
NCT00226356 ↗	Natural Supplements for Unipolar Depression	Completed	Cambridge Health Alliance	Phase 4	2004-12-01	This study is being conducted to determine the clinical response rate for the regimen of L-methionine, betaine and folate for unipolar depression.
NCT00283387 ↗	Efficacy of Betaine for Reduction of Urine Oxalate in Patients With Type 1 Primary Hyperoxaluria	Completed	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	Phase 2	2007-02-01	The aim of this study is to assess the efficacy and safety of betaine in reducing urine oxalate excretion of Type 1 Primary Hyperoxaluria (PHI) patients. Hypothesis: Betaine will effectively reduce urine oxalate excretion in Primary Hyperoxaluria Type I patients.
NCT00283387 ↗	Efficacy of Betaine for Reduction of Urine Oxalate in Patients With Type 1 Primary Hyperoxaluria	Completed	Orphan Europe	Phase 2	2007-02-01	The aim of this study is to assess the efficacy and safety of betaine in reducing urine oxalate excretion of Type 1 Primary Hyperoxaluria (PHI) patients. Hypothesis: Betaine will effectively reduce urine oxalate excretion in Primary Hyperoxaluria Type I patients.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for BETAINE

Condition Name

Chart
Table

Condition Name for BETAINE
Intervention	Trials
Homocystinuria	3
Chronic Hepatitis C	2
Healthy	2
Heart Rate Variability	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for BETAINE
Intervention	Trials
Homocystinuria	4
Hepatitis, Chronic	3
Hepatitis C, Chronic	3
Hepatitis C	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for BETAINE

Trials by Country

Map
Table

Trials by Country for BETAINE
Location	Trials
United States	19
Canada	4
Italy	2
Switzerland	1
Bangladesh	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for BETAINE
Location	Trials
California	4
Massachusetts	3
North Carolina	2
Nebraska	2
Minnesota	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for BETAINE

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for BETAINE
Clinical Trial Phase	Trials
Phase 4	5
Phase 3	2
Phase 2/Phase 3	1
[disabled in preview]	12
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for BETAINE
Clinical Trial Phase	Trials
Completed	20
Terminated	2
Unknown status	1
[disabled in preview]	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for BETAINE

Sponsor Name

Chart
Table

Sponsor Name for BETAINE
Sponsor	Trials
University of California, San Francisco	3
McGill University Health Center	2
Mayo Clinic	2
[disabled in preview]	5
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for BETAINE
Sponsor	Trials
Other	46
Industry	2
NIH	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.